Andrew Schwartz, an analyst with Celent, discusses the decline in insurtech funding and the associated factors, including lackluster return on investment from past spending.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.